AlphaYouOS
Schedule 13G filing
Oxford Science Enterprises plc cut its Barinthus Biotherapeutics plc. (BRNS) stake below 5%
Oxford Science Enterprises plc reported owning 0% of Barinthus Biotherapeutics plc. (BRNS) in a Schedule 13G filed Sep 11, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 11, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.